|

Ferric derisomaltose Clinical Trials

3 actively recruiting trials across 1 location

Also known as: MONOFERRIC

Pipeline

Phase 3: 2

Top Sponsors

  • University Hospital Southampton NHS Foundation Trust1
  • Pharmacosmos A/S1
  • AHS Cancer Control Alberta1

Indications

  • Iron Deficiencies2
  • Heart Disease2
  • Chronic Heart Failure1
  • Iron-deficiency1
  • Anemia1

Other2 trials

Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Phase 3
IRONHEART: Intravenous Iron in Non-ischaemic Heart Failure

Pasadena, California1 trial

Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

Private clinic

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.